The Suboxone lawsuits currently are primarily located, in federal court in the northern district of Ohio. And relatively, that litigation is fairly young. Myself and my other co leads in that litigation have been putting the case into a position to where we can start working up trial cases so that we can see how these cases will end up in front of a jury, what kind of values juries will put on these cases, so that we can get compensation for everybody involved in litigation. In terms of what the big hurdles are in the Suboxone litigation, we’ve already overcome one. The court has ruled on a preliminary motion to dismiss that was filed by the defendants and denied their motion. The next big hurdle for us is going to be likely another motion to dismiss filed by the defense related to federal preemption, which the court has indicated it will not be happy to grant for defense. So we anticipate winning that as well. Beyond that, the biggest issue in many of these cases, and Spoxone’s no exception, is when it comes to presenting our experts in these cases and giving expert testimony so that a jury can understand what the science is behind this case, the court becomes a gatekeeper for that kind of information. And, a big threshold in these cases is for the court to listen to what those experts have to say, read briefing about what they have to say from the attorneys, and make a decision on what, if anything, they will allow to be told to a jury when it comes time for trial. The Suboxone lawsuits currently filed in federal court, I think total around twenty one thousand claimants currently. I would anticipate by the time, we get to our first trial, you could see somewhere north of thirty thousand claimants in this litigation.
